Evidence map›Paper›PMID 30643010›Full record

ArticleBioscience reports2019

p16INK4a inhibits the proliferation of osteosarcoma cells through regulating the miR-146b-5p/TRAF6 pathway.

Mingwei Jiang, Wenjia Lu, Xiaomin Ding, Xiaodong Liu, Zhen Guo, Xu Wu

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Navigating the genomic instability mine field of osteosarcoma to better understand implications of non-coding RNAs.Biocell : official journal of the Sociedades Latinoamericanas de Microscopia Electronica ... et. al · 2022
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mingwei JiangDepartment of Orthopedics, Yangpu Hospital, Tongji University School of Medicine, Shanghai 200090, P.R. China.
Wenjia LuDepartment of Orthopedics, Xinhua People's Hospital, Xinhua City, Jiangsu Province 225700, P.R. China.
Xiaomin DingDepartment of Orthopedics, Yangpu Hospital, Tongji University School of Medicine, Shanghai 200090, P.R. China.
Xiaodong LiuDepartment of Orthopedics, Yangpu Hospital, Tongji University School of Medicine, Shanghai 200090, P.R. China.
Zhen GuoDepartment of Orthopedics, Yangpu Hospital, Tongji University School of Medicine, Shanghai 200090, P.R. China.
Xu WuDepartment of Orthopedics, Yangpu Hospital, Tongji University School of Medicine, Shanghai 200090, P.R. China qyznr84@163.com.ORCID 0000-0002-3968-3430
Yangpu Hospital of Tongji University · CNHubei Provincial Hospital of Integrative Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Down-regulation of p16INK4a and miR-146b-5p contributes to tumorigenesis in osteosarcoma (OS). However, the correlation between p16INK4a and miR-146b-5p in OS proliferation remains largely unknown. In the present study, we demonstrated that miR-146b-5p expression was positively correlated with p16INK4a in OS, but inversely correlated with TNF receptor associated factor 6 (TRAF6) expression. Overexpression of miR-146b-5p dramatically suppressed OS cell proliferation. Mechanistically, we validated TRAF6 as a direct functional target of miR-146b-5p and found that miR-146b-5p overexpression significantly decreased the level of phosphorylated PI3k and Akt, which are the pivotal downstream effectors of TRAF6. Moreover, TRAF6 expression was positively correlated with Ki-67 but inversely correlated with miR-146b-5p expression. In OS cells, silencing of TRAF6 mimicked the anti-tumor effects of miR-146b-5p. p16INK4a is an important tumor suppressor gene frequently down-regulated in OS. We found that this inhibitory effect is associated with the suppression of the miR-146b-5p, and is mediated via up-regulating TRAF6 expression. Our findings identified p16INK4a and miR-146b-5p as tumor suppressors, and suggested p16INK4a, miR-146b-5p and TRAF6 as potential therapeutic candidates for malignant OS.

Indexed as

Bone NeoplasmsCell Line, TumorCell MovementCyclin-Dependent Kinase Inhibitor p16Gene Expression Regulation, NeoplasticHumansIntracellular Signaling Peptides and ProteinsMicroRNAsOsteosarcomaPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktCDKN2A protein, humanCyclin-Dependent Kinase Inhibitor p16Intracellular Signaling Peptides and ProteinsMicroRNAsMIRN146 microRNA, humanPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTifab protein, humanmiR-146b-5pOsteosarcoma Cellsp16INK4atumor suppressors

Identifiers

PMID30643010
PMCPMC6356052
OpenAlexW2910104049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.